(2022). Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England. Cardiovasc Diabetol, 21, 8. http://doi.org/10.1186/s12933-021-01435-y.
(2020). Comparative effectiveness of gliclazide modified release vs sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes. Diabetes Obes Metab. http://doi.org/10.1111/dom.14169.
(2021). Rates and estimated cost of primary care consultations in people diagnosed with type 2 diabetes and comorbidities: A retrospective analysis of 8.9 million consultations. Diabetes Obes Metab. http://doi.org/10.1111/dom.14340.
(2021). Ethnic, social and multimorbidity disparities in therapeutic inertia: a UK primary care observational study in patients newly diagnosed with type 2 diabetes. Diabetes Obes Metab. http://doi.org/10.1111/dom.14482.